Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MAXCYTE, INC.MXCT · Entity 6608 | Chief Financial Officer | March 20, 2023 | March 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MAXCYTE, INC.
Report date March 20, 2023 · Filed March 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.19 · Expires 2033-03-19 | Direct | 120,000 |
Reported balance
After 2023-03-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-20 · Grant · Acquired 120,000 · Balance 120,000 F1: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2023 Filed Mar 21, 2023 16:46 UTC | MAXCYTE, INC. MXCT · Entity 6608 | GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020298 · doc4.xml · derivative · entry 1 Holtz Ron · CIK 0001874490 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:18 UTC | MAXCYTE, INC. MXCT · Entity 6608 | GrantEmployee Stock Option (right to buy) · Derivative | 142,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021470 · doc4.xml · derivative · entry 1 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 Underlying: Common Stock · 142,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| November 16, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 39,130 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · derivative · entry 9 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,292 Underlying: Common Stock · 39,130 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 16, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | SaleCommon Stock | 39,130 | $12.08 | $472,690.40 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · nonDerivative · entry 6 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,251 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 16, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | Exercise / conversionCommon Stock | 39,130 | $0.04 | $1,565.20 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · nonDerivative · entry 5 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 64,385 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · derivative · entry 8 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,422 Underlying: Common Stock · 64,385 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | SaleCommon Stock | 64,385 | $12.16 | $782,921.60 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · nonDerivative · entry 4 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,251 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | Exercise / conversionCommon Stock | 64,385 | $0.04 | $2,575.40 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · nonDerivative · entry 3 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,485 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · derivative · entry 7 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,807 Underlying: Common Stock · 21,485 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | SaleCommon Stock | 46,485 | $12.65 | $588,035.25 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · nonDerivative · entry 2 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,251 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:09 UTC | MAXCYTE, INC. MXCT · Entity 6608 | Exercise / conversionCommon Stock | 21,485 | $0.04 | $859.40 |
DisclosureSEC source: 0001209191-21-064878 · doc4.xml · nonDerivative · entry 1 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 17:15 UTC | MAXCYTE, INC. MXCT · Entity 6608 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.63 | $0.00 |
DisclosureSEC source: 0001209191-21-050938 · doc4.xml · derivative · entry 1 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-08-09 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.